Rimonabant is the well known weight loss drug which helps to treat overweight or obesity related problems very effectively. It was approved for marketing in the European Union by the name Acomplia in June 2006 and the same drug will be sold in United States by the name of Zimulti if approved by the FDA.
This medication works in a very unique way. It blocks receptors that would otherwise receive messages of hunger and transmit those messages to the brain.
Rimonabant produces sustained weight loss, helps to quit smoking, improves blood makers, improves high-density lipoprotein (HDL) cholesterol and triglyceride levels.
In studies, one third of subjects who took Rimonabant lost 10% of their total body weight, and they were able to keep that weight off for at least two years.
More about Acomplia.
More about Zimulti.
Click here to buy Rimonabant.
